Aug 01, 2024 6:00am EDT Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain
Mar 13, 2024 6:00am EDT Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025
Mar 12, 2024 6:00am EDT Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe
Feb 27, 2024 6:00am EST Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries
Feb 22, 2024 6:00am EST Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators
Feb 14, 2024 6:00am EST Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01